AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Net income margin (%)

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.2B
P/E ratio
21.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
May 31, 2025-0.6-7.97%
May 31, 2024-0.6-194.15%
May 31, 20230.7-24.85%
May 31, 20220.9+9.00%
May 31, 20210.8-28.37%
May 31, 20201.1+2456.23%
May 31, 20190-186.64%
May 31, 2018-0.1-488.17%
May 31, 20170-98.32%
May 31, 20160.8+36.58%
May 31, 20150.6-40.26%
May 31, 20141-66.38%
May 31, 20132.9+23.98%
May 31, 20122.3+10.37%
May 31, 20112.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)